Tech Company Financing Transactions

Labster Funding Round

On 4/26/2019, Labster raised $21 million in Series B financing from Owl Ventures, Balderton Capital and EduCapital.

Transaction Overview

Company Name
Labster
Announced On
4/26/2019
Transaction Type
Venture Equity
Amount
$21,000,000
Round
Series B
Investors

Owl Ventures (Lead Investor) (Tory Patterson)

Balderton Capital (Lars Fjeldsoe-Nielsen)

EduCapital

Entangled

private investors (David Helgason)

Nordic Makers

Northzone Ventures

Swisscom

Proceeds Purpose
This latest round will accelerate the expansion of Labster's STEM content catalog and development of new lab simulations, giving students and educators alike even more access to realistic lab experiences.

Company Information

Company Status
Private & Independent
Industry
EdTech
Mailing Address
561 Windsor St. B302
Somerville, MA 02143
USA
Phone
Undisclosed
Website
www.labster.com
Email Address
Not Recorded
Overview
Labster is a company dedicated to developing fully interactive advanced lab simulations based on mathematical algorithms that support open-ended investigations.
Profile
Labster LinkedIn Company Profile
Social Media
Labster Company Twitter Account
Company News
Labster News
Facebook
Labster on Facebook
YouTube
Labster on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Mads Bonde
  Mads Bonde LinkedIn Profile  Mads Bonde Twitter Account  Mads Bonde News  Mads Bonde on Facebook
Chief Technical Officer
Michael Bodekaer
  Michael Bodekaer LinkedIn Profile  Michael Bodekaer Twitter Account  Michael Bodekaer News  Michael Bodekaer on Facebook
VP - Marketing
Mikkel Winther-Lange
  Mikkel Winther-Lange LinkedIn Profile  Mikkel Winther-Lange Twitter Account  Mikkel Winther-Lange News  Mikkel Winther-Lange on Facebook
VP - Operations
Rune Ørndrup
  Rune Ørndrup LinkedIn Profile  Rune Ørndrup Twitter Account  Rune Ørndrup News  Rune Ørndrup on Facebook

 

 

Browse more venture capital transactions:

Prev: 4/26/2019: Savonix venture capital transaction
Next: 4/26/2019: Satsuma Pharmaceuticals venture capital transaction

 

Share this article

 

About Our Venture Capital Transactions Database

We do our best to report on funding rounds that are announced publicly. VC investment data records reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.